Abstract
Key Points TAVR effective in CS, but mortality still high and outcomes determined by non‐procedural factors AS with intact LV ejection fraction rarely induces CS: Must delineate non‐valvular hemodynamic compromise factors “Primary” TAVR strategy preferable, with BAV reserved as “Bridge” to Definitive Decision
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
